Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

Patients' perspectives of living with Sjögren disease: A systematic review of qualitative studies from the OMERACT Sjögren disease working group

The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanisms

The immune cell landscape analysed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's disease

Single-Cell Spatial Transcriptomic of Sjögren's Disease Salivary Glands

Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis

A Systematic Review of Clinical Trial Designs and Outcome Measures in Sjögren Disease Randomized Controlled Trials

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)

Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data

Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study

"If I have Sjögren's syndrome, I want to know it as early as possible": The perspective of first-degree relatives of patients with Sjögren's syndrome from an international survey

Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation

Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group

The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation

High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome

Phenotypic, transcriptomic, and spatial characterization of CD45RB(+) naïve mature B cells: Implications in Sjögren's disease

Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease

French national diagnostic and care protocol for Sjögren's disease

Usefulness of 18F-FDG PET-CT in detecting subclinical arteritis and cancer associated with polymyalgia rheumatica

Optimal Formalin-Fixed Paraffin-Embedded Sample Preservation for Efficient Staining in Multiplex Imaging

B-Cell involvement in immune checkpoint inhibitor-induced lichen planus: A comparative analysis with non-drug-related lichen planus

[Between the normal and the pathological: The concept of pre-disease applied to systemic autoimmune rheumatic diseases]

GM-CSF drives IL-6 production by macrophages in polymyalgia rheumatica

BiomiX, a user-friendly bioinformatic tool for democratized analysis and integration of multiomics data

Aging in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: From Pathophysiology to Clinical Management

CAR T-cell therapy in autoimmune diseases: where are we and where are we going?

Identification of the central tolerance checkpoint for autoreactive proteinase 3(+) B cells in human bone marrow

Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures

Maf expression in B cells restricts reactive plasmablast and germinal center B cell expansion

Reply

Concordance and agreement between different activity scores in polymyalgia rheumatica

Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis

Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell Arteritis

Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica

[(18)F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica

Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial

[Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus]

Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus

An interactive web application for exploring systemic lupus erythematosus blood transcriptomic diversity

Complex relationships between inflammatory manifestations/type 1 and type 2 symptoms in systemic lupus erythematosus: A narrative literature review

Prevalence and Significance of the Presence of Anti-transglutaminase and Anti-endomysium Antibodies in Patients with Early Inflammatory Joint Disease

Commentary: Prevalence and incidence of celiac disease in patients with rheumatoid arthritis: a case-control study based on the RECORD cohort

Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry

Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial

Dual MPO/PR3 ANCA positivity and vasculitis: insights from a 7-cases study and an AI-powered literature review

Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice

Clinical presentation and treatment response in ACPA-negative rheumatoid arthritis

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

Evaluation of a nurse-led program for the prevention of complications of long-term glucocorticoids (COCORTICO): study protocol for a randomized trial

Practical management of rheumatic immune-related adverse events occurring with immune checkpoint inhibitors: A narrative review